Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 1
1970 1
1973 2
1975 6
1976 3
1977 5
1978 4
1979 7
1980 3
1981 3
1982 1
1983 3
1984 8
1985 4
1986 13
1987 153
1988 345
1989 429
1990 442
1991 503
1992 450
1993 508
1994 479
1995 525
1996 490
1997 494
1998 431
1999 463
2000 497
2001 534
2002 561
2003 608
2004 619
2005 568
2006 488
2007 502
2008 519
2009 590
2010 531
2011 544
2012 554
2013 577
2014 908
2015 1091
2016 884
2017 713
2018 1210
2019 1127
2020 1212
2021 1277
2022 1169
2023 1022
2024 586
2025 291

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,861 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for tucson t
Search for Tuzson T instead (1 results)
Surgical Management of Diabetic Macular Edema.
Prince J, Kumar D, Ghosh A, Arevalo JF, Zhang AY. Prince J, et al. Curr Diab Rep. 2023 Jun;23(6):119-125. doi: 10.1007/s11892-023-01505-3. Epub 2023 Apr 12. Curr Diab Rep. 2023. PMID: 37043090 Review.
Modeling ventricular parasystole.
Courtemanche M, Glass L, Rosengarten MD. Courtemanche M, et al. Ann N Y Acad Sci. 1990;591:178-89. doi: 10.1111/j.1749-6632.1990.tb15088.x. Ann N Y Acad Sci. 1990. PMID: 2197920 Review. No abstract available.
CD4(+) T Cell-Specific Proteomic Pathways Identified in Progression of Hypertension Across Postmenopausal Transition.
Uhlorn JA, Husband NA, Romero-Aleshire MJ, Moffett C, Lindsey ML, Langlais PR, Brooks HL. Uhlorn JA, et al. J Am Heart Assoc. 2021 Jan 19;10(2):e018038. doi: 10.1161/JAHA.120.018038. Epub 2021 Jan 7. J Am Heart Assoc. 2021. PMID: 33410333 Free PMC article.
Compared with premenopausal T cells, Ang II infusion in menopausal mice increased T cell phosphorylation of MP2K2, an upstream regulator of ERK, and was associated with upregulated phosphorylation at ERK targeted sites. ...Conclusions These findings identify novel, …
Compared with premenopausal T cells, Ang II infusion in menopausal mice increased T cell phosphorylation of MP2K2, an upstream …
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.
Bauman JE, Saba NF, Roe D, Bauman JR, Kaczmar J, Bhatia A, Muzaffar J, Julian R, Wang S, Bearelly S, Baker A, Steuer C, Giri A, Burtness B, Centuori S, Caulin C, Klein R, Saboda K, Obara S, Chung CH. Bauman JE, et al. J Clin Oncol. 2023 Aug 1;41(22):3851-3862. doi: 10.1200/JCO.22.01994. Epub 2023 Mar 28. J Clin Oncol. 2023. PMID: 36977289 Clinical Trial.
The Potential of Topoisomerase Inhibitor-Based Antibody-Drug Conjugates.
Han S, Lim KS, Blackburn BJ, Yun J, Putnam CW, Bull DA, Won YW. Han S, et al. Pharmaceutics. 2022 Aug 16;14(8):1707. doi: 10.3390/pharmaceutics14081707. Pharmaceutics. 2022. PMID: 36015333 Free PMC article. Review.
Some TOP1-ADCs have shown enhanced therapeutic efficacy compared to prototypical anti-cancer ADCs, such as T-DM1. Here, we review various types of camptothecin-based TOP1 inhibitors and recent developments in TOP1-ADCs. ...
Some TOP1-ADCs have shown enhanced therapeutic efficacy compared to prototypical anti-cancer ADCs, such as T-DM1. Here, we review var …
The role of T helper type 17 cells in inflammatory arthritis.
Sarkar S, Cooney LA, Fox DA. Sarkar S, et al. Clin Exp Immunol. 2010 Mar;159(3):225-37. doi: 10.1111/j.1365-2249.2009.04016.x. Epub 2009 Aug 25. Clin Exp Immunol. 2010. PMID: 19758374 Free PMC article. Review.
While T cells have been implicated in the pathogenesis of inflammatory arthritis for more than three decades, the focus on the T helper type 17 (Th17) subset of CD4 T cells and their secreted cytokines, such as interleukin (IL)-17, is much more recent. ...
While T cells have been implicated in the pathogenesis of inflammatory arthritis for more than three decades, the focus on the T
Peripheral T-Cell Lymphoma in a Patient Previously Diagnosed With Sarcoidosis.
Menghani SV, Diaz-Hanson JP, Heimbigner A, Wakefield C, Fuchs D, Reveles CY, Spier C, Amaraneni A, Kumar A. Menghani SV, et al. J Hematol. 2023 Dec;12(6):272-276. doi: 10.14740/jh1173. Epub 2023 Dec 9. J Hematol. 2023. PMID: 38188478 Free PMC article.
After a thorough workup involving cervical lymph node biopsy and bone marrow biopsy, he was diagnosed with peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS). Due to the patient's current lymphoma diagnosis and features noted on pathology, a retrospective revi …
After a thorough workup involving cervical lymph node biopsy and bone marrow biopsy, he was diagnosed with peripheral T-cell lymphoma …
Age-Related Differences in T-Cell Subsets in a Nationally Representative Sample of People Older Than Age 55: Findings From the Health and Retirement Study.
Thyagarajan B, Faul J, Vivek S, Kim JK, Nikolich-Žugich J, Weir D, Crimmins EM. Thyagarajan B, et al. J Gerontol A Biol Sci Med Sci. 2022 May 5;77(5):927-933. doi: 10.1093/gerona/glab300. J Gerontol A Biol Sci Med Sci. 2022. PMID: 34633448 Free PMC article.
Total T cells (CD3+) and CD4+ cells declined markedly with age; CD8+ T cells declined somewhat less. While CD4+ T cell declines with age occurred for both CMV-seropositive and CMV-seronegative groups, total T cells and CD8+ cells were both substantiall …
Total T cells (CD3+) and CD4+ cells declined markedly with age; CD8+ T cells declined somewhat less. While CD4+ T cell …
22,861 results
You have reached the last available page of results. Please see the User Guide for more information.